EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Lannett Co's enterprise value is $593.4 Mil.
Lannett Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 was $-171.4 Mil. Therefore, Lannett Co's EV-to-EBITDA for today is -3.46.
The historical rank and industry rank for Lannett Co's EV-to-EBITDA or its related term are showing as below:
LCINQ'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -8.26 Med: 7.85 Max: 80.53
Current: -3.46
During the past 13 years, the highest EV-to-EBITDA of Lannett Co was 80.53. The lowest was -8.26. And the median was 7.85.
LCINQ's EV-to-EBITDA is not ranked
in the Drug Manufacturers industry.
Industry Median: 14.6
vs LCINQ: -3.46
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-07), Lannett Co's stock price is $0.02965.
Lannett Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 was $-25.280. Therefore, Lannett Co's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Lannett Co EV-to-EBITDA Historical Data
The historical data trend for Lannett Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Lannett Co's EV-to-EBITDA
For the Drug Manufacturers - Specialty & Generic subindustry, Lannett Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lannett Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lannett Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Lannett Co's EV-to-EBITDA falls into.
Lannett Co EV-to-EBITDA Calculation
Lannett Co's EV-to-EBITDA for today is calculated as:
Lannett Co's current Enterprise Value is $593.4 Mil.
Lannett Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-171.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lannett Co (OTCPK:LCINQ) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Lannett Co's share price for today is $0.02965.
Lannett Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-25.280.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Lannett Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products. It offers solid oral, extended-release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. In addition, the company also provides its products for various medical indications comprising glaucoma, gastrointestinal, migraine, obesity, respiratory, and others. It operates in the segment of generic pharmaceuticals. Its customers include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LCINQ has been successfully added to your 